Literature DB >> 14722478

Patterns of medical resource and psychotropic medicine use among adult depressed managed behavioral health patients.

Francisca Azocar1, Loren M McCarter, Brian J Cuffel, Thomas W Croghan.   

Abstract

Medical and pharmacy utilization patterns were examined among 782 depressed patients seen by independent clinicians through a Managed Behavioral Health Organization using behavioral, medical and pharmacy claims spanning 2 years. Two-thirds received psychiatric care in the medical and mental health sector concurrently, 43% had comorbid medical disorders, 61% received psychotropic medications, and 54% were on antidepressants. Fewer depressed medically comorbid patients used medical services while in mental health treatment than before or after treatment, while the per patient costs remained the same. For those with chronic conditions, medical utilization and costs remained the same. A quarter of depressed patients received mental health treatment before seeing a mental health specialist, and a quarter remained in treatment in the medical sector after treatment in the mental health sector. Despite increases in mental health services access made available through managed behavioral health organizations, patients continue receiving mental health treatment in the medical sector.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14722478     DOI: 10.1007/bf02287336

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  45 in total

1.  Does managing behavioral health care services increase the cost of providing medical care?

Authors:  B J Cuffel; W Goldman; H Schlesinger
Journal:  J Behav Health Serv Res       Date:  1999-11       Impact factor: 1.505

2.  Economic grand rounds: Is there a shortage of psychiatrists?

Authors:  W Goldman
Journal:  Psychiatr Serv       Date:  2001-12       Impact factor: 3.084

3.  Surveillance for asthma--United States, 1960-1995.

Authors:  D M Mannino; D M Homa; C A Pertowski; A Ashizawa; L L Nixon; C A Johnson; L B Ball; E Jack; D S Kang
Journal:  MMWR CDC Surveill Summ       Date:  1998-04-24

4.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

5.  Use of psychiatrists, psychologists, and master's-level therapists in managed behavioral health care carve-out plans.

Authors:  R Sturm; R Klap
Journal:  Psychiatr Serv       Date:  1999-04       Impact factor: 3.084

6.  Cost-effectiveness of a collaborative care program for primary care patients with persistent depression.

Authors:  G E Simon; W J Katon; M VonKorff; J Unützer; E H Lin; E A Walker; T Bush; C Rutter; E Ludman
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

7.  Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability.

Authors:  E A Walker; D Keegan; G Gardner; M Sullivan; W J Katon; D Bernstein
Journal:  Psychosom Med       Date:  1997 Nov-Dec       Impact factor: 4.312

8.  Achieving guidelines for the treatment of depression in primary care: is physician education enough?

Authors:  E H Lin; W J Katon; G E Simon; M Von Korff; T M Bush; C M Rutter; K W Saunders; E A Walker
Journal:  Med Care       Date:  1997-08       Impact factor: 2.983

9.  Service utilization and social morbidity associated with depressive symptoms in the community.

Authors:  J Johnson; M M Weissman; G L Klerman
Journal:  JAMA       Date:  1992-03-18       Impact factor: 56.272

10.  Psychiatric diagnoses, sexual and physical victimization, and disability in patients with irritable bowel syndrome or inflammatory bowel disease.

Authors:  E A Walker; A N Gelfand; M D Gelfand; W J Katon
Journal:  Psychol Med       Date:  1995-11       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.